Last reviewed · How we verify

NCT05035498

Prophylactic Norepinephrine and Phenylephrine Infusion for Hemodynamic Effects in Patients With Preeclampsia

Status unknown NA Last updated 2 February 2024
What this trial tests

NA trial testing Phenylephrine in Hemodynamic Instability in 72 participants. Status unknown.

Timeline
1 February 2024
Primary endpoint
21 April 2025
21 April 2025

Quick facts

Lead sponsorGeneral Hospital of Ningxia Medical University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment72
Start date1 February 2024
Primary completion21 April 2025
Estimated completion21 April 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

General Hospital of Ningxia Medical University

Who can join

Adults 18 to 45, female only, with Hemodynamic Instability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the maternal cardiac output response to prophylactic norepinephrine and phenylephrine infusion for postspinal anesthesia hypotension in parturients with preeclampsia undergoing cesarean section.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Phenylephrine

Trials testing the same drug.

Other recruiting trials for Hemodynamic Instability

Currently open trials in the same condition.

Other General Hospital of Ningxia Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05035498.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing